Kev paub

Suav ua dual antibody ADC tso cai rau Merck

Roche lub peev xwm 'zoo tshaj plaws hauv chav kawm' me me molecule therapy tau tshaj tawm cov txiaj ntsig zoo hauv kev kho mob

Albion tshaj tawm Phase III Clinical Data of COVID-19 Mutant (BA. 4/5) mRNA Vaccine

Taw qhia rau cov khoom siv excipient

Excipients, nyob rau hauv cov tshuaj formulations, yog additives uas tsis yog cov tshuaj tseem ceeb, thiab kuj tseem hu ua excipients. Xws li adhesive

1. Siv los ua cov tshuaj methylation. 2. Yav dhau los tau npaj ua ib feem ntawm fungicides, tshuaj tua kab mob, tshuaj tua kab lossis nematicides, thi

Toxicological cov ntaub ntawv ntawm iodomethane

Cov ntaub ntawv molecular qauv ntawm iodomethane

Melting point: -64 degree Boiling point: 40.3 degree Flash point: 7.8 degree Ceev: 2.28g/cm3 LogP: 1.50 Refractive index: 1.528 tsos: Colorless kua So

Kev sib cuag ntawm daim tawv nqaij: Tshem tawm cov khaub ncaws tsis huv thiab yaug daim tawv nqaij nrog xab npum thiab dej. Kev sib cuag qhov muag: Nq

Kev tiv thaiv ua pa: Thaum cov huab cua nyob hauv huab cua ntau dua tus qauv, ib tus yuav tsum xaiv hnav lub ntsej muag lub ntsej muag lub ntsej muag

Tshem tawm cov neeg ua haujlwm sai sai ntawm thaj chaw muaj kab mob mus rau thaj chaw nyab xeeb, cais lawv, thiab nruj me ntsis txwv kev nkag thiab ta